(Q41634803)

5 October 2017

Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis (English)

1 reference

5 October 2017

0 references

0 references

B Lohr

1

1 reference

5 October 2017

I Müller

2

1 reference

5 October 2017

M Mai

3

1 reference

5 October 2017

D E Norris

4

1 reference

5 October 2017

O Schöffski

5

1 reference

5 October 2017

K-P Hunfeld

6

1 reference

5 October 2017

19 October 2014

1 reference

Ticks and Tick-borne Diseases

5 October 2017

1 reference

5 October 2017

6

1 reference

5 October 2017

1

1 reference

5 October 2017

56-62

1 reference

Cost-of-illness studies : a review of current methods.

5 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Diagnostic challenges of early Lyme disease: lessons from a community case series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Study on public perceptions and protective behaviors regarding Lyme disease among the general public in the Netherlands: implications for prevention programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

An epidemiologic study of Lyme disease in southern Sweden.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Prevalences of tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in Ixodes ricinus populations of the Rhine-Main region, Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Lyme neuroborreliosis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Clinical and epidemiological features of Lyme borreliosis in Bulgaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Seropositivity of Lyme borreliosis and associated risk factors: a population-based study in Children and Adolescents in Germany (KiGGS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Full spectrum of clinical, serological, and epidemiological features of complicated forms of Lyme borreliosis in the Paris, France, area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Tick (Ixodes ricinus) abundance and seasonality at recreational sites in the UK: hazards in relation to fine-scale habitat types revealed by complementary sampling methods.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Borrelia burgdorferi infection and Lyme disease in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Documentation and coding of medical records in a tertiary care center: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Epidemiological situation of Lyme borreliosis in germany: surveillance data from six Eastern German States, 2002 to 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Work based on data of the Gmünder Ersatzkasse. An exemplary overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Community incidence of pathogen-specific gastroenteritis: reconstructing the surveillance pyramid for seven pathogens in seven European Union member states.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Neuroborreliosis--an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Secondary data analysis in the field of epidemiology of health care. Potential and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Incidence of Lyme borreliosis in the Würzburg region of Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

The development, evolution, and modifications of ICD-10: challenges to the international comparability of morbidity data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Lyme disease--what is the cost for Scotland?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

CDC estimates 300,000 US cases of Lyme disease annually

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Disease expression of Lyme borreliosis in northeastern France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

A cost-of-illness study of Lyme disease in the United States.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

[Health economic effects after DRG-implementation--a systematic overview].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Secondary data analysis of large data sets in urology: successes and errors to avoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Lyme borreliosis: clinical case definitions for diagnosis and management in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

The Overdiagnosis of Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Laboratory evaluation in the diagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Indirect costs of disease; an international comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

Economic impact of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2014.09.004

10.1016/J.TTBDIS.2014.09.004

7 January 2021

Identifiers

DOI

1 reference

5 October 2017

1 reference